Merav Bassan
Corporate Officer/Principal at BIOMX INC.
Net worth: - $ as of 2024-04-29
Profile
Merav Bassan is currently the Chief Development Officer at BiomX Ltd.
and BiomX, Inc. She is also a member of 8400 Health Network.
Previously, she worked at Teva Pharmaceutical Industries Ltd.
as Vice President from 2009 to 2019.
She received her undergraduate and graduate degrees from Tel-Aviv University and her doctorate from Sackler School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BIOMX INC.
-.--% | 2024-03-27 | 0 ( -.--% ) | - $ | 2024-04-29 |
Merav Bassan active positions
| Companies | Position | Start |
|---|---|---|
| BIOMX INC. | Corporate Officer/Principal | 2019-10-27 |
BiomX Ltd.
 BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Corporate Officer/Principal | 2019-09-30 |
| 8400 Health Network | Corporate Officer/Principal | - |
Former positions of Merav Bassan
| Companies | Position | End |
|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 2018-12-31 |
Training of Merav Bassan
| Tel-Aviv University | Graduate Degree |
| Sackler School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| BIOMX INC. | Health Technology |
| Private companies | 2 |
|---|---|
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Health Technology |
| 8400 Health Network |
- Stock Market
- Insiders
- Merav Bassan